Log in

BioSig Technologies Stock Forecast, Price & News

-0.09 (-1.75 %)
(As of 10/21/2020 12:00 AM ET)
Today's Range
Now: $5.06
50-Day Range
MA: $6.25
52-Week Range
Now: $5.06
Volume151,782 shs
Average Volume670,251 shs
Market Capitalization$150.02 million
P/E RatioN/A
Dividend YieldN/A
BioSig Technologies, Inc., a medical technology company, engages in developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. The company's first product, PURE EPTM System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The system is indicated for use under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. This novel cardiac signal acquisition and display system is engineered to assist electrophysiologists in clinical decision-making during electrophysiology procedures in patients with abnormal heart rates and rhythms. The company has partnered with Minnetronix on technology development and received FDA 510(k) clearance for the PURE EPTM System in August 2018. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company has partnership with Albany Molecular Research Inc. for support in undertaking research to investigate the potential of merimepodib to fight SARS-CoV-2, the virus that causes COVID-19 as a standalone treatment or in combination with other anti-viral agents or immune modulators. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.24 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolNASDAQ:BSGM



Sales & Book Value

Annual SalesN/A
Book Value$0.53 per share


Net Income$-34,060,000.00


Market Cap$150.02 million
Next Earnings Date10/28/2020 (Estimated)
OptionableNot Optionable
-0.09 (-1.75 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BSGM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

BioSig Technologies (NASDAQ:BSGM) Frequently Asked Questions

How has BioSig Technologies' stock been impacted by COVID-19 (Coronavirus)?

BioSig Technologies' stock was trading at $3.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BSGM shares have increased by 61.1% and is now trading at $5.06.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of BioSig Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for BioSig Technologies

When is BioSig Technologies' next earnings date?

BioSig Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for BioSig Technologies

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) issued its earnings results on Thursday, August, 6th. The company reported ($0.72) EPS for the quarter.
View BioSig Technologies' earnings history

What price target have analysts set for BSGM?

1 equities research analysts have issued 1 year price targets for BioSig Technologies' stock. Their forecasts range from $9.00 to $9.00. On average, they anticipate BioSig Technologies' share price to reach $9.00 in the next twelve months. This suggests a possible upside of 77.9% from the stock's current price.
View analysts' price targets for BioSig Technologies

Who are some of BioSig Technologies' key competitors?

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

Who are BioSig Technologies' key executives?

BioSig Technologies' management team includes the following people:
  • Mr. Kenneth L. Londoner M.B.A., MBA, Founder, CEO & Exec. Chairman (Age 52, Pay $1.01M)
  • Mr. Steven Chaussy, Chief Financial Officer (Age 66)
  • Dr. Budimir S. Drakulic Ph.D., Chief Scientist (Age 70)
  • Ms. Lora Mikolaitis, VP of Admin. (Age 47)
  • Mr. Andrew Gornell Ballou, VP of Investor Relations

What is BioSig Technologies' stock symbol?

BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM."

How do I buy shares of BioSig Technologies?

Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioSig Technologies' stock price today?

One share of BSGM stock can currently be purchased for approximately $5.06.

How big of a company is BioSig Technologies?

BioSig Technologies has a market capitalization of $150.02 million. BioSig Technologies employs 33 workers across the globe.

What is BioSig Technologies' official website?

The official website for BioSig Technologies is www.biosig.com.

How can I contact BioSig Technologies?

BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The company can be reached via phone at 203-409-5444 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.